Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,8735509,duration,"The mean (SD) duration of anaesthesia was 64.8 (3.1) minutes for group 1 and 60 (0) minutes for group 2; the mean total dose of propofol given to the sheep in group 1 was 801 (84) mg, and the sheep in group 2 received 470 (46) mg of propofol and 267 (30) mg of ketamine.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,64.8,26609,DB01614,Acepromazine
,8735509,duration,"The mean (SD) duration of anaesthesia was 64.8 (3.1) minutes for group 1 and 60 (0) minutes for group 2; the mean total dose of propofol given to the sheep in group 1 was 801 (84) mg, and the sheep in group 2 received 470 (46) mg of propofol and 267 (30) mg of ketamine.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,60,26610,DB01614,Acepromazine
,8735509,elimination half-life,"The mean elimination half-life of propofol was 56.6 (13.1) minutes in group 1 and 50.3 (21.4) minutes in group 2; the mean volume of distribution at steady state was 1.037 (0.480) litre kg-1 in group 1 and 1.515 (0.939) litre kg-1 in group 2; the mean body clearance was 85.4 (28.0) ml kg-1 min-1 in group 1 and 128.0 (35.0) ml kg-1 min-1 in group 2; the mean residence time corrected for a bolus injection was 12.1 (4.2) minutes in group 1 and 11.9 (6.6) minutes in group 2; for the infusion, the mean residence time was 72.1 (4.2) minutes in group 1 and 69.9 (7.9) minutes in group 2.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,56.6,26611,DB01614,Acepromazine
,8735509,elimination half-life,"The mean elimination half-life of propofol was 56.6 (13.1) minutes in group 1 and 50.3 (21.4) minutes in group 2; the mean volume of distribution at steady state was 1.037 (0.480) litre kg-1 in group 1 and 1.515 (0.939) litre kg-1 in group 2; the mean body clearance was 85.4 (28.0) ml kg-1 min-1 in group 1 and 128.0 (35.0) ml kg-1 min-1 in group 2; the mean residence time corrected for a bolus injection was 12.1 (4.2) minutes in group 1 and 11.9 (6.6) minutes in group 2; for the infusion, the mean residence time was 72.1 (4.2) minutes in group 1 and 69.9 (7.9) minutes in group 2.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,50.3,26612,DB01614,Acepromazine
,8735509,volume of distribution at steady state,"The mean elimination half-life of propofol was 56.6 (13.1) minutes in group 1 and 50.3 (21.4) minutes in group 2; the mean volume of distribution at steady state was 1.037 (0.480) litre kg-1 in group 1 and 1.515 (0.939) litre kg-1 in group 2; the mean body clearance was 85.4 (28.0) ml kg-1 min-1 in group 1 and 128.0 (35.0) ml kg-1 min-1 in group 2; the mean residence time corrected for a bolus injection was 12.1 (4.2) minutes in group 1 and 11.9 (6.6) minutes in group 2; for the infusion, the mean residence time was 72.1 (4.2) minutes in group 1 and 69.9 (7.9) minutes in group 2.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",Vss-Q65,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),[l] / [kg],1.037,26613,DB01614,Acepromazine
,8735509,volume of distribution at steady state,"The mean elimination half-life of propofol was 56.6 (13.1) minutes in group 1 and 50.3 (21.4) minutes in group 2; the mean volume of distribution at steady state was 1.037 (0.480) litre kg-1 in group 1 and 1.515 (0.939) litre kg-1 in group 2; the mean body clearance was 85.4 (28.0) ml kg-1 min-1 in group 1 and 128.0 (35.0) ml kg-1 min-1 in group 2; the mean residence time corrected for a bolus injection was 12.1 (4.2) minutes in group 1 and 11.9 (6.6) minutes in group 2; for the infusion, the mean residence time was 72.1 (4.2) minutes in group 1 and 69.9 (7.9) minutes in group 2.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",Vss-Q65,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),[l] / [kg],1.515,26614,DB01614,Acepromazine
,8735509,body clearance,"The mean elimination half-life of propofol was 56.6 (13.1) minutes in group 1 and 50.3 (21.4) minutes in group 2; the mean volume of distribution at steady state was 1.037 (0.480) litre kg-1 in group 1 and 1.515 (0.939) litre kg-1 in group 2; the mean body clearance was 85.4 (28.0) ml kg-1 min-1 in group 1 and 128.0 (35.0) ml kg-1 min-1 in group 2; the mean residence time corrected for a bolus injection was 12.1 (4.2) minutes in group 1 and 11.9 (6.6) minutes in group 2; for the infusion, the mean residence time was 72.1 (4.2) minutes in group 1 and 69.9 (7.9) minutes in group 2.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),[ml] / [kg·min],85.4,26615,DB01614,Acepromazine
,8735509,body clearance,"The mean elimination half-life of propofol was 56.6 (13.1) minutes in group 1 and 50.3 (21.4) minutes in group 2; the mean volume of distribution at steady state was 1.037 (0.480) litre kg-1 in group 1 and 1.515 (0.939) litre kg-1 in group 2; the mean body clearance was 85.4 (28.0) ml kg-1 min-1 in group 1 and 128.0 (35.0) ml kg-1 min-1 in group 2; the mean residence time corrected for a bolus injection was 12.1 (4.2) minutes in group 1 and 11.9 (6.6) minutes in group 2; for the infusion, the mean residence time was 72.1 (4.2) minutes in group 1 and 69.9 (7.9) minutes in group 2.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),[ml] / [kg·min],128.0,26616,DB01614,Acepromazine
,8735509,mean residence time,"The mean elimination half-life of propofol was 56.6 (13.1) minutes in group 1 and 50.3 (21.4) minutes in group 2; the mean volume of distribution at steady state was 1.037 (0.480) litre kg-1 in group 1 and 1.515 (0.939) litre kg-1 in group 2; the mean body clearance was 85.4 (28.0) ml kg-1 min-1 in group 1 and 128.0 (35.0) ml kg-1 min-1 in group 2; the mean residence time corrected for a bolus injection was 12.1 (4.2) minutes in group 1 and 11.9 (6.6) minutes in group 2; for the infusion, the mean residence time was 72.1 (4.2) minutes in group 1 and 69.9 (7.9) minutes in group 2.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",MRT-Q53,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,12.1,26617,DB01614,Acepromazine
,8735509,mean residence time,"The mean elimination half-life of propofol was 56.6 (13.1) minutes in group 1 and 50.3 (21.4) minutes in group 2; the mean volume of distribution at steady state was 1.037 (0.480) litre kg-1 in group 1 and 1.515 (0.939) litre kg-1 in group 2; the mean body clearance was 85.4 (28.0) ml kg-1 min-1 in group 1 and 128.0 (35.0) ml kg-1 min-1 in group 2; the mean residence time corrected for a bolus injection was 12.1 (4.2) minutes in group 1 and 11.9 (6.6) minutes in group 2; for the infusion, the mean residence time was 72.1 (4.2) minutes in group 1 and 69.9 (7.9) minutes in group 2.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",MRT-Q53,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,11.9,26618,DB01614,Acepromazine
,8735509,mean residence time,"The mean elimination half-life of propofol was 56.6 (13.1) minutes in group 1 and 50.3 (21.4) minutes in group 2; the mean volume of distribution at steady state was 1.037 (0.480) litre kg-1 in group 1 and 1.515 (0.939) litre kg-1 in group 2; the mean body clearance was 85.4 (28.0) ml kg-1 min-1 in group 1 and 128.0 (35.0) ml kg-1 min-1 in group 2; the mean residence time corrected for a bolus injection was 12.1 (4.2) minutes in group 1 and 11.9 (6.6) minutes in group 2; for the infusion, the mean residence time was 72.1 (4.2) minutes in group 1 and 69.9 (7.9) minutes in group 2.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",MRT-Q53,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,72.1,26619,DB01614,Acepromazine
,8735509,mean residence time,"The mean elimination half-life of propofol was 56.6 (13.1) minutes in group 1 and 50.3 (21.4) minutes in group 2; the mean volume of distribution at steady state was 1.037 (0.480) litre kg-1 in group 1 and 1.515 (0.939) litre kg-1 in group 2; the mean body clearance was 85.4 (28.0) ml kg-1 min-1 in group 1 and 128.0 (35.0) ml kg-1 min-1 in group 2; the mean residence time corrected for a bolus injection was 12.1 (4.2) minutes in group 1 and 11.9 (6.6) minutes in group 2; for the infusion, the mean residence time was 72.1 (4.2) minutes in group 1 and 69.9 (7.9) minutes in group 2.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",MRT-Q53,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,69.9,26620,DB01614,Acepromazine
,8735509,times to extubation,"All the sheep recovered quickly from anaesthesia; the mean times to extubation, sternal recumbency and standing for the animals in group 1 were 2.8 (0.4), 6.3 (1.2) and 10.9 (1.6) minutes from the end of the infusion, and the times for group 2 were 5.3 (0.9), 11.2 (1.7) and 15.1 (2.2) minutes.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,2.8,26621,DB01614,Acepromazine
,8735509,times to extubation,"All the sheep recovered quickly from anaesthesia; the mean times to extubation, sternal recumbency and standing for the animals in group 1 were 2.8 (0.4), 6.3 (1.2) and 10.9 (1.6) minutes from the end of the infusion, and the times for group 2 were 5.3 (0.9), 11.2 (1.7) and 15.1 (2.2) minutes.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,6.3,26622,DB01614,Acepromazine
,8735509,times to extubation,"All the sheep recovered quickly from anaesthesia; the mean times to extubation, sternal recumbency and standing for the animals in group 1 were 2.8 (0.4), 6.3 (1.2) and 10.9 (1.6) minutes from the end of the infusion, and the times for group 2 were 5.3 (0.9), 11.2 (1.7) and 15.1 (2.2) minutes.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,10.9,26623,DB01614,Acepromazine
,8735509,times to extubation,"All the sheep recovered quickly from anaesthesia; the mean times to extubation, sternal recumbency and standing for the animals in group 1 were 2.8 (0.4), 6.3 (1.2) and 10.9 (1.6) minutes from the end of the infusion, and the times for group 2 were 5.3 (0.9), 11.2 (1.7) and 15.1 (2.2) minutes.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,5.3,26624,DB01614,Acepromazine
,8735509,times,"All the sheep recovered quickly from anaesthesia; the mean times to extubation, sternal recumbency and standing for the animals in group 1 were 2.8 (0.4), 6.3 (1.2) and 10.9 (1.6) minutes from the end of the infusion, and the times for group 2 were 5.3 (0.9), 11.2 (1.7) and 15.1 (2.2) minutes.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,5.3,26625,DB01614,Acepromazine
,8735509,times,"All the sheep recovered quickly from anaesthesia; the mean times to extubation, sternal recumbency and standing for the animals in group 1 were 2.8 (0.4), 6.3 (1.2) and 10.9 (1.6) minutes from the end of the infusion, and the times for group 2 were 5.3 (0.9), 11.2 (1.7) and 15.1 (2.2) minutes.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,11.2,26626,DB01614,Acepromazine
,8735509,times,"All the sheep recovered quickly from anaesthesia; the mean times to extubation, sternal recumbency and standing for the animals in group 1 were 2.8 (0.4), 6.3 (1.2) and 10.9 (1.6) minutes from the end of the infusion, and the times for group 2 were 5.3 (0.9), 11.2 (1.7) and 15.1 (2.2) minutes.","Pharmacokinetics of propofol infusions, either alone or with ketamine, in sheep premedicated with acepromazine and papaveretum. ",tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8735509/),min,15.1,26627,DB01614,Acepromazine
,10582751,heart rate,Mean heart rate of all dogs varied from 52 to 140 beats/min during the infusion.,Total intravenous anesthesia in greyhounds: pharmacokinetics of propofol and fentanyl--a preliminary study. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10582751/),[beats] / [min],52 to 140,28977,DB01614,Acepromazine
,10582751,times,"Mean times (+/- SEM), after termination of the propofol infusion, to return of spontaneous ventilation, extubation, head lift and standing for all dogs were 26 +/- 7, 30 +/- 7, 59 +/- 12, and 105 +/- 13 minutes, respectively.",Total intravenous anesthesia in greyhounds: pharmacokinetics of propofol and fentanyl--a preliminary study. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10582751/),min,26,28978,DB01614,Acepromazine
,10582751,times,"Mean times (+/- SEM), after termination of the propofol infusion, to return of spontaneous ventilation, extubation, head lift and standing for all dogs were 26 +/- 7, 30 +/- 7, 59 +/- 12, and 105 +/- 13 minutes, respectively.",Total intravenous anesthesia in greyhounds: pharmacokinetics of propofol and fentanyl--a preliminary study. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10582751/),min,30,28979,DB01614,Acepromazine
,10582751,times,"Mean times (+/- SEM), after termination of the propofol infusion, to return of spontaneous ventilation, extubation, head lift and standing for all dogs were 26 +/- 7, 30 +/- 7, 59 +/- 12, and 105 +/- 13 minutes, respectively.",Total intravenous anesthesia in greyhounds: pharmacokinetics of propofol and fentanyl--a preliminary study. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10582751/),min,59,28980,DB01614,Acepromazine
,10582751,times,"Mean times (+/- SEM), after termination of the propofol infusion, to return of spontaneous ventilation, extubation, head lift and standing for all dogs were 26 +/- 7, 30 +/- 7, 59 +/- 12, and 105 +/- 13 minutes, respectively.",Total intravenous anesthesia in greyhounds: pharmacokinetics of propofol and fentanyl--a preliminary study. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10582751/),min,105,28981,DB01614,Acepromazine
,10582751,Mean residence time (MRTinf),"Mean residence time (MRTinf) for propofol was 104.7 +/- 6.0 minutes, mean body clearance (Clb) was 53.35 +/- 0.005 mL/kg/min, and volume of distribution at steady state (Vdss) was 3.27 +/- 0.49 L/kg.",Total intravenous anesthesia in greyhounds: pharmacokinetics of propofol and fentanyl--a preliminary study. ,MRT-Q53,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10582751/),min,104.7,28982,DB01614,Acepromazine
,10582751,body clearance (Clb),"Mean residence time (MRTinf) for propofol was 104.7 +/- 6.0 minutes, mean body clearance (Clb) was 53.35 +/- 0.005 mL/kg/min, and volume of distribution at steady state (Vdss) was 3.27 +/- 0.49 L/kg.",Total intravenous anesthesia in greyhounds: pharmacokinetics of propofol and fentanyl--a preliminary study. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10582751/),[ml] / [kg·min],53.35,28983,DB01614,Acepromazine
,10582751,volume of distribution at steady state (Vdss),"Mean residence time (MRTinf) for propofol was 104.7 +/- 6.0 minutes, mean body clearance (Clb) was 53.35 +/- 0.005 mL/kg/min, and volume of distribution at steady state (Vdss) was 3.27 +/- 0.49 L/kg.",Total intravenous anesthesia in greyhounds: pharmacokinetics of propofol and fentanyl--a preliminary study. ,Vss-Q65,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10582751/),[l] / [kg],3.27,28984,DB01614,Acepromazine
,10582751,Plasma concentration,Plasma concentration of fentanyl for seven dogs during the infusion varied from 1.22 to 4.54 ng/mL.,Total intravenous anesthesia in greyhounds: pharmacokinetics of propofol and fentanyl--a preliminary study. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10582751/),[ng] / [ml],1.22 to 4.54,28985,DB01614,Acepromazine
,10582751,MRTinf,MRTinf for fentanyl was 111.3 +/- 5.7 minutes.,Total intravenous anesthesia in greyhounds: pharmacokinetics of propofol and fentanyl--a preliminary study. ,MRT-Q53,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10582751/),min,111.3,28986,DB01614,Acepromazine
,10582751,body clearance,Mean body clearance was 29.1 +/- 2.2 mL/kg/min and Vdss was 2.21 +/- 0.19 L/kg.,Total intravenous anesthesia in greyhounds: pharmacokinetics of propofol and fentanyl--a preliminary study. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10582751/),[ml] / [kg·min],29.1,28987,DB01614,Acepromazine
,10582751,Vdss,Mean body clearance was 29.1 +/- 2.2 mL/kg/min and Vdss was 2.21 +/- 0.19 L/kg.,Total intravenous anesthesia in greyhounds: pharmacokinetics of propofol and fentanyl--a preliminary study. ,Vss-Q65,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10582751/),[l] / [kg],2.21,28988,DB01614,Acepromazine
,30208893,VTI,"The median (range) VTI and VTI*HR were similar at the two time points [11.9(8.1-17.3) vs 13,3(9,4-16,5) cm, and 1172(806-1554) vs 1002(630-1159) cm*bpm, respectively].",Haemodynamic changes during propofol induction in dogs: new findings and approach of monitoring. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/30208893/),cm,11.9,40762,DB01614,Acepromazine
,30208893,VTI*HR,"The median (range) VTI and VTI*HR were similar at the two time points [11.9(8.1-17.3) vs 13,3(9,4-16,5) cm, and 1172(806-1554) vs 1002(630-1159) cm*bpm, respectively].",Haemodynamic changes during propofol induction in dogs: new findings and approach of monitoring. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/30208893/),bpm·cm,1172,40763,DB01614,Acepromazine
,30208893,VTI*HR,"The median (range) VTI and VTI*HR were similar at the two time points [11.9(8.1-17.3) vs 13,3(9,4-16,5) cm, and 1172(806-1554) vs 1002(630-1159) cm*bpm, respectively].",Haemodynamic changes during propofol induction in dogs: new findings and approach of monitoring. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/30208893/),bpm·cm,1002,40764,DB01614,Acepromazine
,10493642,Tmax,"Tmax was 31 mins in the control group, and this increased significantly (P<.05) after sedation.",The effect of sedation on gastric emptying of a liquid marker in ponies. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10493642/),min,31,58609,DB01614,Acepromazine
<,7998701,alpha-phase distribution half-life,Intravenously administered doses led to a biphasic concentration decay pattern with an alpha-phase distribution half-life of < 3 minutes.,Pharmacokinetics and pharmacodynamics of acepromazine in horses. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7998701/),min,3,78280,DB01614,Acepromazine
,7998701,beta-phase half-life,The beta-phase half-life was in the range of 50 to 150 minutes.,Pharmacokinetics and pharmacodynamics of acepromazine in horses. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/7998701/),min,50 to 150,78281,DB01614,Acepromazine
,30713053,infusion rate,The median (range) alfaxalone infusion rate was 3.1 (2.4-4.3) mg kg-1 hour-1.,Alfaxalone for total intravenous anaesthesia in horses. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/30713053/),[mg] / [h·kg],3.1,89475,DB01614,Acepromazine
,30713053,plasma elimination half-life,"The mean ± standard deviation plasma elimination half-life, plasma clearance and volume of distribution for alfaxalone were 41 minutes, 25 ± 6.3 mL minute-1 kg-1 and 1.6 ± 0.5 L kg-1, respectively.",Alfaxalone for total intravenous anaesthesia in horses. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/30713053/),min,41,89476,DB01614,Acepromazine
,30713053,plasma clearance,"The mean ± standard deviation plasma elimination half-life, plasma clearance and volume of distribution for alfaxalone were 41 minutes, 25 ± 6.3 mL minute-1 kg-1 and 1.6 ± 0.5 L kg-1, respectively.",Alfaxalone for total intravenous anaesthesia in horses. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/30713053/),[ml] / [kg·min],25,89477,DB01614,Acepromazine
,30713053,volume of distribution,"The mean ± standard deviation plasma elimination half-life, plasma clearance and volume of distribution for alfaxalone were 41 minutes, 25 ± 6.3 mL minute-1 kg-1 and 1.6 ± 0.5 L kg-1, respectively.",Alfaxalone for total intravenous anaesthesia in horses. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/30713053/),[l] / [kg],1.6,89478,DB01614,Acepromazine
,7853456,half-life,"In plasma, a very short initial distribution phase in both horses and ponies, half-life 1.4 +/- 1.2 min (mean +/- SD) and 1.3 +/- 0.7 min, respectively, was obtained, which was followed by a second comparatively slower redistribution phase, half-life 16 +/- 12 min and 11 +/- 5 min, respectively.",Pharmacokinetics of thiopentone in the horse. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7853456/),min,1.4,135041,DB01614,Acepromazine
,7853456,half-life,"In plasma, a very short initial distribution phase in both horses and ponies, half-life 1.4 +/- 1.2 min (mean +/- SD) and 1.3 +/- 0.7 min, respectively, was obtained, which was followed by a second comparatively slower redistribution phase, half-life 16 +/- 12 min and 11 +/- 5 min, respectively.",Pharmacokinetics of thiopentone in the horse. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7853456/),min,1.3,135042,DB01614,Acepromazine
,7853456,half-life,"In plasma, a very short initial distribution phase in both horses and ponies, half-life 1.4 +/- 1.2 min (mean +/- SD) and 1.3 +/- 0.7 min, respectively, was obtained, which was followed by a second comparatively slower redistribution phase, half-life 16 +/- 12 min and 11 +/- 5 min, respectively.",Pharmacokinetics of thiopentone in the horse. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7853456/),min,16,135043,DB01614,Acepromazine
,7853456,half-life,"In plasma, a very short initial distribution phase in both horses and ponies, half-life 1.4 +/- 1.2 min (mean +/- SD) and 1.3 +/- 0.7 min, respectively, was obtained, which was followed by a second comparatively slower redistribution phase, half-life 16 +/- 12 min and 11 +/- 5 min, respectively.",Pharmacokinetics of thiopentone in the horse. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7853456/),min,11,135044,DB01614,Acepromazine
,7853456,volume of distribution,"The volume of distribution for the drug was large, especially in the ponies which received isoflurane (1127 +/- 86 ml/kg), compared to the horses which received halothane (742 +/- 89 ml/kg).",Pharmacokinetics of thiopentone in the horse. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7853456/),[ml] / [kg],1127,135045,DB01614,Acepromazine
,7853456,volume of distribution,"The volume of distribution for the drug was large, especially in the ponies which received isoflurane (1127 +/- 86 ml/kg), compared to the horses which received halothane (742 +/- 89 ml/kg).",Pharmacokinetics of thiopentone in the horse. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7853456/),[ml] / [kg],742,135046,DB01614,Acepromazine
,7853456,elimination half-life,"The drug had a somewhat shorter elimination half-life in the horses (147 +/- 21 min) than in than ponies (222 +/- 44 min), but no obvious difference in clearance of the drug was observed between the horses (3.5 +/- 0.5 ml/min/kg) and ponies (3.6 +/- 0.8 ml/min/kg).",Pharmacokinetics of thiopentone in the horse. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/7853456/),min,147,135047,DB01614,Acepromazine
,7853456,elimination half-life,"The drug had a somewhat shorter elimination half-life in the horses (147 +/- 21 min) than in than ponies (222 +/- 44 min), but no obvious difference in clearance of the drug was observed between the horses (3.5 +/- 0.5 ml/min/kg) and ponies (3.6 +/- 0.8 ml/min/kg).",Pharmacokinetics of thiopentone in the horse. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/7853456/),min,222,135048,DB01614,Acepromazine
,7853456,clearance,"The drug had a somewhat shorter elimination half-life in the horses (147 +/- 21 min) than in than ponies (222 +/- 44 min), but no obvious difference in clearance of the drug was observed between the horses (3.5 +/- 0.5 ml/min/kg) and ponies (3.6 +/- 0.8 ml/min/kg).",Pharmacokinetics of thiopentone in the horse. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7853456/),[ml] / [kg·min],3.5,135049,DB01614,Acepromazine
,7853456,clearance,"The drug had a somewhat shorter elimination half-life in the horses (147 +/- 21 min) than in than ponies (222 +/- 44 min), but no obvious difference in clearance of the drug was observed between the horses (3.5 +/- 0.5 ml/min/kg) and ponies (3.6 +/- 0.8 ml/min/kg).",Pharmacokinetics of thiopentone in the horse. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7853456/),[ml] / [kg·min],3.6,135050,DB01614,Acepromazine
,25943714,plasma concentrations,Mean fentanyl plasma concentrations were 1.6-4.5 ng mL(-1) during isoflurane anesthesia and 1.6-2.0 ng mL(-1) during recovery from anesthesia.,Effects of acepromazine or dexmedetomidine on fentanyl disposition in dogs during recovery from isoflurane anesthesia. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/25943714/),[ng] / [ml],1.6-4.5,140789,DB01614,Acepromazine
,25943714,plasma concentrations,Mean fentanyl plasma concentrations were 1.6-4.5 ng mL(-1) during isoflurane anesthesia and 1.6-2.0 ng mL(-1) during recovery from anesthesia.,Effects of acepromazine or dexmedetomidine on fentanyl disposition in dogs during recovery from isoflurane anesthesia. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/25943714/),[ng] / [ml],1.6-2.0,140790,DB01614,Acepromazine
,25943714,volume of the central compartment,Recovery from isoflurane anesthesia without sedation was associated with an increase in the volume of the central compartment from 0.80 to 1.02 L kg(-1).,Effects of acepromazine or dexmedetomidine on fentanyl disposition in dogs during recovery from isoflurane anesthesia. ,V1-Q63,[Article Link](https://pubmed.ncbi.nlm.nih.gov/25943714/),[l] / [kg],0.80,140791,DB01614,Acepromazine
,25943714,volume of the central compartment,Recovery from isoflurane anesthesia without sedation was associated with an increase in the volume of the central compartment from 0.80 to 1.02 L kg(-1).,Effects of acepromazine or dexmedetomidine on fentanyl disposition in dogs during recovery from isoflurane anesthesia. ,V1-Q63,[Article Link](https://pubmed.ncbi.nlm.nih.gov/25943714/),[l] / [kg],1.02,140792,DB01614,Acepromazine
,25943714,systemic clearance,"After administration of acepromazine, systemic clearance of fentanyl increased from 31.5 to 40.3 mL minute(-1) kg(-1) and the volume of the central compartment increased from 0.70 to 0.94 L kg(-1).",Effects of acepromazine or dexmedetomidine on fentanyl disposition in dogs during recovery from isoflurane anesthesia. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/25943714/),[ml] / [kg·minute],31.5 to 40.3,140793,DB01614,Acepromazine
,25943714,volume of the central compartment,"After administration of acepromazine, systemic clearance of fentanyl increased from 31.5 to 40.3 mL minute(-1) kg(-1) and the volume of the central compartment increased from 0.70 to 0.94 L kg(-1).",Effects of acepromazine or dexmedetomidine on fentanyl disposition in dogs during recovery from isoflurane anesthesia. ,V1-Q63,[Article Link](https://pubmed.ncbi.nlm.nih.gov/25943714/),[l] / [kg],0,140794,DB01614,Acepromazine
,19339028,Cp,PropCp reached 7.65+/-2.1 microg ml(-1) at the end of the study.,Correlation between clinical signs of depth of anaesthesia and cerebral state index responses in dogs during induction of anaesthesia with propofol. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19339028/),[μg] / [ml],7.65,156197,DB01614,Acepromazine
,19339028,CSI,CSI values at T0 were 89.2+/-3.8.,Correlation between clinical signs of depth of anaesthesia and cerebral state index responses in dogs during induction of anaesthesia with propofol. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19339028/),,89.2,156198,DB01614,Acepromazine
,19339028,HR,MAP decreased significantly from T0 until loss of corneal reflex (from 98+/-14 mm Hg to 82+/-12 mm Hg); HR did not change significantly (from 101+/-30 bpm to 113+/-16 bpm).,Correlation between clinical signs of depth of anaesthesia and cerebral state index responses in dogs during induction of anaesthesia with propofol. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19339028/),bpm,101,156199,DB01614,Acepromazine
,19339028,HR,MAP decreased significantly from T0 until loss of corneal reflex (from 98+/-14 mm Hg to 82+/-12 mm Hg); HR did not change significantly (from 101+/-30 bpm to 113+/-16 bpm).,Correlation between clinical signs of depth of anaesthesia and cerebral state index responses in dogs during induction of anaesthesia with propofol. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/19339028/),bpm,113,156200,DB01614,Acepromazine
,6492246,rate of change in volume of distribution at zero time,"The rate of change in volume of distribution at zero time (mean +/- SD, n = 7), which is a parameter that might have been expected to vary significantly, was 97 +/- 106 ml/min X kg for thiopental alone and 77 +/- 60 ml/min X kg following acetylpromazine premedication.",Effect of premedication with acetylpromazine on the disposition kinetics of thiopental. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6492246/),[ml] / [kg·min],97,158424,DB01614,Acepromazine
,6492246,rate of change in volume of distribution at zero time,"The rate of change in volume of distribution at zero time (mean +/- SD, n = 7), which is a parameter that might have been expected to vary significantly, was 97 +/- 106 ml/min X kg for thiopental alone and 77 +/- 60 ml/min X kg following acetylpromazine premedication.",Effect of premedication with acetylpromazine on the disposition kinetics of thiopental. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6492246/),[ml] / [kg·min],77,158425,DB01614,Acepromazine
,6492246,Body clearance,Body clearance of thiopental was 1.96 +/- 0.59 ml/min X kg in dogs without premedication and 1.55 +/- 0.49 ml/min X kg following acetylpromazine.,Effect of premedication with acetylpromazine on the disposition kinetics of thiopental. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6492246/),[ml] / [kg·min],1.96,158426,DB01614,Acepromazine
,6492246,Body clearance,Body clearance of thiopental was 1.96 +/- 0.59 ml/min X kg in dogs without premedication and 1.55 +/- 0.49 ml/min X kg following acetylpromazine.,Effect of premedication with acetylpromazine on the disposition kinetics of thiopental. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6492246/),[ml] / [kg·min],1.55,158427,DB01614,Acepromazine
,8318329,infusion rate,"In the seventh dog, the infusion rate was increased to 0.6 mg kg-1 min-1 in order to achieve surgical anaesthesia.",Pharmacokinetics of propofol administered by infusion in dogs undergoing surgery. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8318329/),[mg] / [kg·min],0.6,164654,DB01614,Acepromazine
,8318329,elimination half-life,"The mean elimination half-life was 322.3 (sem 27.0) min, mean volume of distribution at steady state 6.510 (0.524) litre kg-1, mean body clearance 50.1 (3.9) ml kg-1 min-1 and mean residence time 131.6 (8.9) min.",Pharmacokinetics of propofol administered by infusion in dogs undergoing surgery. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/8318329/),min,322.3,164655,DB01614,Acepromazine
,8318329,volume of distribution at steady state,"The mean elimination half-life was 322.3 (sem 27.0) min, mean volume of distribution at steady state 6.510 (0.524) litre kg-1, mean body clearance 50.1 (3.9) ml kg-1 min-1 and mean residence time 131.6 (8.9) min.",Pharmacokinetics of propofol administered by infusion in dogs undergoing surgery. ,Vss-Q65,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8318329/),[l] / [kg],6.510,164656,DB01614,Acepromazine
,8318329,body clearance,"The mean elimination half-life was 322.3 (sem 27.0) min, mean volume of distribution at steady state 6.510 (0.524) litre kg-1, mean body clearance 50.1 (3.9) ml kg-1 min-1 and mean residence time 131.6 (8.9) min.",Pharmacokinetics of propofol administered by infusion in dogs undergoing surgery. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8318329/),[ml] / [kg·min],50.1,164657,DB01614,Acepromazine
,8318329,mean residence time,"The mean elimination half-life was 322.3 (sem 27.0) min, mean volume of distribution at steady state 6.510 (0.524) litre kg-1, mean body clearance 50.1 (3.9) ml kg-1 min-1 and mean residence time 131.6 (8.9) min.",Pharmacokinetics of propofol administered by infusion in dogs undergoing surgery. ,MRT-Q53,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8318329/),min,131.6,164658,DB01614,Acepromazine
,8318329,time to extubation,The mean time to extubation was 7.6 min and to standing unaided was 30.7 min from the end of the infusion.,Pharmacokinetics of propofol administered by infusion in dogs undergoing surgery. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8318329/),min,7.6,164659,DB01614,Acepromazine
,8318329,time to extubation,The mean time to extubation was 7.6 min and to standing unaided was 30.7 min from the end of the infusion.,Pharmacokinetics of propofol administered by infusion in dogs undergoing surgery. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8318329/),min,30.7,164660,DB01614,Acepromazine
,33950785,"maximum concentrations (Cmax,)","Mean (SD) maximum concentrations (Cmax,) of morphine in plasma were 6.8 (4.56), 9.56 (8.29), 9.30 (3.35) and 18.99 (9.41) ng/mL for the groups Dex + Mor, Dex + Maro + Mor, Maro + Mor and Mor respectively.","Evaluation of analgesic interaction between morphine, maropitant and dexmedetomidine in dogs undergoing ovariohysterectomy. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/33950785/),[ng] / [ml],6.8,171104,DB01614,Acepromazine
,33950785,"maximum concentrations (Cmax,)","Mean (SD) maximum concentrations (Cmax,) of morphine in plasma were 6.8 (4.56), 9.56 (8.29), 9.30 (3.35) and 18.99 (9.41) ng/mL for the groups Dex + Mor, Dex + Maro + Mor, Maro + Mor and Mor respectively.","Evaluation of analgesic interaction between morphine, maropitant and dexmedetomidine in dogs undergoing ovariohysterectomy. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/33950785/),[ng] / [ml],9.56,171105,DB01614,Acepromazine
,33950785,"maximum concentrations (Cmax,)","Mean (SD) maximum concentrations (Cmax,) of morphine in plasma were 6.8 (4.56), 9.56 (8.29), 9.30 (3.35) and 18.99 (9.41) ng/mL for the groups Dex + Mor, Dex + Maro + Mor, Maro + Mor and Mor respectively.","Evaluation of analgesic interaction between morphine, maropitant and dexmedetomidine in dogs undergoing ovariohysterectomy. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/33950785/),[ng] / [ml],9.30,171106,DB01614,Acepromazine
,33950785,"maximum concentrations (Cmax,)","Mean (SD) maximum concentrations (Cmax,) of morphine in plasma were 6.8 (4.56), 9.56 (8.29), 9.30 (3.35) and 18.99 (9.41) ng/mL for the groups Dex + Mor, Dex + Maro + Mor, Maro + Mor and Mor respectively.","Evaluation of analgesic interaction between morphine, maropitant and dexmedetomidine in dogs undergoing ovariohysterectomy. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/33950785/),[ng] / [ml],18.99,171107,DB01614,Acepromazine
,23317425,clearance (Cl/F(PM),"The clearance (Cl/F(PM)) and volume of distribution (V/F(PM)), scaled by the fraction of parent converted to metabolite, were estimated as 769 L/h and 6874 L, respectively.",A Bayesian approach for estimating detection times in horses: exploring the pharmacokinetics of a urinary acepromazine metabolite. ,CLpo-Q27,[Article Link](https://pubmed.ncbi.nlm.nih.gov/23317425/),[l] / [h],769,175606,DB01614,Acepromazine
,23317425,volume of distribution (V/F(PM)),"The clearance (Cl/F(PM)) and volume of distribution (V/F(PM)), scaled by the fraction of parent converted to metabolite, were estimated as 769 L/h and 6874 L, respectively.",A Bayesian approach for estimating detection times in horses: exploring the pharmacokinetics of a urinary acepromazine metabolite. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/23317425/),l,6874,175607,DB01614,Acepromazine
,22774843,pseudo-steady state concentrations,"Blood propofol concentrations during the infusion ranged between 1.52 and 7.65 μg/mL; pseudo-steady state concentrations 3.64-6.78 μg/mL, and concentrations on assuming standing position 0.75-1.40 μg/mL.",Real time monitoring of propofol blood concentration in ponies anaesthetized with propofol and ketamine. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/22774843/),[μg] / [ml],3.64-6.78,179623,DB01614,Acepromazine
,22774843,clearance,"Propofol clearance and volume of distribution were 31.4 (SD 6.1) mL/min/kg and 220.7 (132.0) mL/kg, respectively.",Real time monitoring of propofol blood concentration in ponies anaesthetized with propofol and ketamine. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/22774843/),[ml] / [kg·min],31.4,179624,DB01614,Acepromazine
,22774843,volume of distribution,"Propofol clearance and volume of distribution were 31.4 (SD 6.1) mL/min/kg and 220.7 (132.0) mL/kg, respectively.",Real time monitoring of propofol blood concentration in ponies anaesthetized with propofol and ketamine. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/22774843/),[ml] / [kg],220.7,179625,DB01614,Acepromazine
,21831048,durations,"The mean ± SD durations of anaesthesia from induction to sternal recumbency and from induction to standing were 42.7 ± 8.4 and 47 ± 9.6 minutes, respectively.",The pharmacokinetics and pharmacodynamics of the injectable anaesthetic alfaxalone in the horse. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/21831048/),min,42.7,183125,DB01614,Acepromazine
,21831048,durations,"The mean ± SD durations of anaesthesia from induction to sternal recumbency and from induction to standing were 42.7 ± 8.4 and 47 ± 9.6 minutes, respectively.",The pharmacokinetics and pharmacodynamics of the injectable anaesthetic alfaxalone in the horse. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/21831048/),min,47,183126,DB01614,Acepromazine
,21831048,plasma elimination half life (t(1/2) ),"The mean ± SD plasma elimination half life (t(1/2) ), plasma clearance (Clp) and volume of distribution (V(d) ) for alfaxalone were 33.4 minutes, 37.1 ± 11.1 mL minute(-1) kg(-1) and 1.6 ± 0.4 L kg(-1) , respectively.",The pharmacokinetics and pharmacodynamics of the injectable anaesthetic alfaxalone in the horse. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/21831048/),min,33.4,183127,DB01614,Acepromazine
,21831048,plasma clearance (Clp),"The mean ± SD plasma elimination half life (t(1/2) ), plasma clearance (Clp) and volume of distribution (V(d) ) for alfaxalone were 33.4 minutes, 37.1 ± 11.1 mL minute(-1) kg(-1) and 1.6 ± 0.4 L kg(-1) , respectively.",The pharmacokinetics and pharmacodynamics of the injectable anaesthetic alfaxalone in the horse. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/21831048/),[ml] / [kg·minute],37.1,183128,DB01614,Acepromazine
,21831048,volume of distribution (V(d) ),"The mean ± SD plasma elimination half life (t(1/2) ), plasma clearance (Clp) and volume of distribution (V(d) ) for alfaxalone were 33.4 minutes, 37.1 ± 11.1 mL minute(-1) kg(-1) and 1.6 ± 0.4 L kg(-1) , respectively.",The pharmacokinetics and pharmacodynamics of the injectable anaesthetic alfaxalone in the horse. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/21831048/),[l] / [kg],1.6,183129,DB01614,Acepromazine
,1425314,half-life,The elimination was slower after oral administration (half-life 15.9 h) than after i. v. injection (half-life 7.1 h).,[The pharmacokinetics and bioavailability of acepromazine in the plasma of dogs]. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1425314/),h,15.9,188879,DB01614,Acepromazine
,1425314,half-life,The elimination was slower after oral administration (half-life 15.9 h) than after i. v. injection (half-life 7.1 h).,[The pharmacokinetics and bioavailability of acepromazine in the plasma of dogs]. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1425314/),h,7.1,188880,DB01614,Acepromazine
,1425314,bioavailability,The bioavailability of the orally administered drug formulation averaged 20%.,[The pharmacokinetics and bioavailability of acepromazine in the plasma of dogs]. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1425314/),%,20,188881,DB01614,Acepromazine
,31806432,target plasma concentration (TPC),"Dogs were allocated to group fTCI [target plasma concentration (TPC) 1 ng mL-1] or group PNB (nerve stimulator-guided femoral-sciatic block using 0.2 and 0.1 mL kg-1 of levobupivacaine 0.5%, respectively).",Peripheral nerve block versus systemic analgesia in dogs undergoing tibial plateau levelling osteotomy: Analgesic efficacy and pharmacoeconomics comparison. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31806432/),[ng] / [ml],1,190829,DB01614,Acepromazine
,2920698,half-life of elimination,The half-life of elimination of phenylbutazone alone was about 4 h.,"Interactions between chloramphenicol, acepromazine, phenylbutazone, rifampin and thiamylal in the horse. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/2920698/),h,4,198483,DB01614,Acepromazine
,7097847,Vd,"After intravenous (i.v.) injection, acepromazine was distributed widely in the horse (Vd = 6.6 litres/kg) and bound extensively (greater than 99%) plasma proteins.","The pharmacokinetics, pharmacological responses and behavioral effects of acepromazine in the horse. ",V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7097847/),[l] / [kg],6.6,212459,DB01614,Acepromazine
,7097847,alpha half-life,"Plasma levels of drug declined with an alpha half-life of 4.2 min, while the beta phase or elimination half-life was 184.8 min.","The pharmacokinetics, pharmacological responses and behavioral effects of acepromazine in the horse. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7097847/),min,4.2,212460,DB01614,Acepromazine
,7097847,beta phase,"Plasma levels of drug declined with an alpha half-life of 4.2 min, while the beta phase or elimination half-life was 184.8 min.","The pharmacokinetics, pharmacological responses and behavioral effects of acepromazine in the horse. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/7097847/),min,184.8,212461,DB01614,Acepromazine
,7097847,elimination half-life,"Plasma levels of drug declined with an alpha half-life of 4.2 min, while the beta phase or elimination half-life was 184.8 min.","The pharmacokinetics, pharmacological responses and behavioral effects of acepromazine in the horse. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/7097847/),min,184.8,212462,DB01614,Acepromazine
,29457257,elimination half-life,"The mean ± SEM elimination half-life was 5.16 ± 0.450, 8.58 ± 2.23, and 6.70 ± 2.62 hr following intravenous, oral, and SL administration, respectively.","Pharmacokinetics, pharmacodynamics, and metabolism of acepromazine following intravenous, oral, and sublingual administration to exercised Thoroughbred horses. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/29457257/),h,5.16,232127,DB01614,Acepromazine
,29457257,elimination half-life,"The mean ± SEM elimination half-life was 5.16 ± 0.450, 8.58 ± 2.23, and 6.70 ± 2.62 hr following intravenous, oral, and SL administration, respectively.","Pharmacokinetics, pharmacodynamics, and metabolism of acepromazine following intravenous, oral, and sublingual administration to exercised Thoroughbred horses. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/29457257/),h,8.58,232128,DB01614,Acepromazine
,29457257,elimination half-life,"The mean ± SEM elimination half-life was 5.16 ± 0.450, 8.58 ± 2.23, and 6.70 ± 2.62 hr following intravenous, oral, and SL administration, respectively.","Pharmacokinetics, pharmacodynamics, and metabolism of acepromazine following intravenous, oral, and sublingual administration to exercised Thoroughbred horses. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/29457257/),h,6.70,232129,DB01614,Acepromazine
,8230407,half-life,"The drug was rapidly absorbed after p.o. administration with a half-life of 0.84 h, tmax of 0.4 h and Cmax of 59 ng/ml.","Disposition, bioavailability and clinical efficacy of orally administered acepromazine in the horse. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8230407/),h,0.84,260858,DB01614,Acepromazine
,8230407,tmax,"The drug was rapidly absorbed after p.o. administration with a half-life of 0.84 h, tmax of 0.4 h and Cmax of 59 ng/ml.","Disposition, bioavailability and clinical efficacy of orally administered acepromazine in the horse. ",tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8230407/),h,0.4,260859,DB01614,Acepromazine
,8230407,Cmax,"The drug was rapidly absorbed after p.o. administration with a half-life of 0.84 h, tmax of 0.4 h and Cmax of 59 ng/ml.","Disposition, bioavailability and clinical efficacy of orally administered acepromazine in the horse. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8230407/),[ng] / [ml],59,260860,DB01614,Acepromazine
,8230407,half-life,The elimination was slower after p.o. administration (half-life 6.04 h) than after i.v. injection (half-life 2.6 h).,"Disposition, bioavailability and clinical efficacy of orally administered acepromazine in the horse. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8230407/),h,6.04,260861,DB01614,Acepromazine
,8230407,half-life,The elimination was slower after p.o. administration (half-life 6.04 h) than after i.v. injection (half-life 2.6 h).,"Disposition, bioavailability and clinical efficacy of orally administered acepromazine in the horse. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8230407/),h,2.6,260862,DB01614,Acepromazine
,8230407,bioavailability,The bioavailability of the orally administered drug formulation was 55.1%.,"Disposition, bioavailability and clinical efficacy of orally administered acepromazine in the horse. ",F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8230407/),%,55.1,260863,DB01614,Acepromazine
